Bio Saga Headlines

Bio Saga

Tuesday, March 10, 2009

Roche raises Genentech bid to $45.7bn

Roche has upped its offer for Genentech to $93 a share, believing that this will be sufficient to bring the drawn out takeover to a close.

The bid is still a long way short of the $112 that Genentech is alleged to have valued itself at, according to a Roche filing with the US Securities and Exchange Commission.

Despite this, and the possibility that positive data from Avastin trials could send Genentech’s share price over $100, Franz Humer, chairman of the Roche Group, is confident the deal will go through.

Genentech has urged shareholders not to act until the Special Committee has taken a formal position, which will happen “promptly”.




Be part of XTractor community.

  • XTractor the first of its kind - Literature alert service, provides manually curated & annotated sentences for the Keywords of your choice
  • XTractor maps, extracted entities (genes, processes, drugs, diseases etc) to multiple ontologies
  • Enables customized report generation. With XTractor the sentences are categorized into biologically significant relationships
  • The categorized sentences could then be tagged and shared across multiple users
  • Provides users with the ability to create his own database for a set of Key terms
  • Users could change the Keywords of preference from time to time, with changing research needs
  • XTractor thus proves to be a platform for getting real-time highly accurate data along with the ability to Share and collaborate


Sign up it's free, and takes less than a minute. Just click here:www.xtractor.in.











No comments:

Life Science and Informatics

What is this?
is this a new industry?
or a old wine in a new bottle?

Well Life Sciences and Informatics can be anything form computational biology, all omes and omics, core bioinformatics to curation and literature mining, database creation, in the area of biology, chemistry , bio-chem space.

There are number of companies in India and bangalore is the forefront as a major bio-cluster with 20 to 30 companies in this sphere.

now how good are these companies doing?
how good are they in terms of the international markets and how profitable is their business?
what do they do?
their clients?

These are some interesting things that could be discussed in this blog page...

Tag It